FDA Inspection 1237501 — Dakhil, Dr Shaker
The FDA completed an inspection of Dakhil, Dr Shaker on April 26, 2024 in Wichita, KS. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- April 26, 2024
- Fiscal Year
- 2024
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Wichita, KS (United States)
Additional Details
Clinical Investigator (CI)